Status:
COMPLETED
Neuro-ophthalmology and Autoimmune Encephalitis (NODE)
Lead Sponsor:
Hospices Civils de Lyon
Conditions:
Autoimmune Encephalitis
Eligibility:
All Genders
18-70 years
Brief Summary
Autoimmune encephalitis represents a group of rare and heterogeneous neurological disorders. Pathophysiological mechanisms in these diseases are still unknown. Recently, oculomotor and neurovisual dis...
Eligibility Criteria
Inclusion
- Diagnosis of autoimmune encephalitis
- With or without pathological antibody
- Aged from 18 to 70 years old
- Able to understand the aims and methods of this project
- Non opposed to the participation of this study
Exclusion
- Other neurological, psychiatric or systemic conditions, which could induce neuro-ophthalmological signs Cognitive impairment, which is not linked to autoimmune encephalitis
- Ophthalmological condition, which could modify the interpretation of neuro-ophthalmological data Inability to remain seated
- Pregnancy or breast feeding
- Adults under guardianship
Key Trial Info
Start Date :
January 22 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 26 2020
Estimated Enrollment :
2 Patients enrolled
Trial Details
Trial ID
NCT03872284
Start Date
January 22 2020
End Date
February 26 2020
Last Update
January 10 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospices Civils de Lyon
Bron, France, 69500